CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
research
Effect of ranitidine on acetaminophen-induced hepatotoxicity in dogs
Authors
A Francavilla
A Francavilla
+27 more
A Francavilla
A Francavilla
A. Francavilla
BG Gazzard
BL Blitzer
C. Panella
D. H. Van Thiel
DJ Miller
F. W. Guglielmi
J. Demetris
J. G. Prelich
JI Routh
JR Powell
KV Speeg
L Ortega
L Zieve
L. Makowka
L. Polimeno
M. Barone
R Kanashima
S Rendic
S Rendic
S. Bell
S. Rizzi
SJ Atwood
T. E. Starzl
TB Leonard
Publication date
1 January 1990
Publisher
'Springer Science and Business Media LLC'
Doi
View
on
PubMed
Abstract
The effect of ranitidine administration upon the hepatotoxic effect produced by a multidose acetaminophen administration regimen was examined. Seventy-two dogs received three subcutaneous injections of acetaminophen (750, 200, 200 mg/kg body wt) in DMSO (600 mg/ml) at time zero, 9 hr later, and 24 hr after the first dose. Ten control animals (group I) were not given ranitidine, the remaining 62 dogs received an intramus-cular injection of ranitidine 30 min before each acetaminophen dose. Three different doses of ranitidine were used (mg/kg body wt): 50 mg, group II (33 dogs); 75 mg, group III (14 dogs); 120 mg, group IV (15 dogs). Ranitidine reduced the expected acetaminophen-induced hepatoxicity in a dose-response manner. Moreover, a significant correlation was found between the ranitidine dose and the survival rate, as evidenced by transaminase levels in the serum and histology of the liver. This model of fulminant hepatic failure induced by acetaminophen and its modulation with ranitidine provides clinical investigators with a research tool that will be useful in the future investigation of putative medical and surgical therapies being investigated for use in the clinical management of fulminant hepatic failure. Because of the size of the animal used in this model, frequent and serial analyses of blood and liver were available for study to determine the effect of therapy within a given animal as opposed to within groups of animals. © 1990 Plenum Publishing Corporation
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
D-Scholarship@Pitt
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:d-scholarship.pitt.edu:449...
Last time updated on 19/07/2013
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 31/03/2019
Archivio Istituzionale della Ricerca- Università degli Studi di Foggia
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:fair.unifg.it:11369/6754
Last time updated on 03/09/2019
Name not available
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:d-scholarship.pitt.edu:449...
Last time updated on 23/11/2016
Archivio istituzionale della ricerca - Università di Bari
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ricerca.uniba.it:11586/108...
Last time updated on 12/11/2016